Cleared Traditional

CAPRI (K254271) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K254271 · ORO Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2026
Decision
58d
Days
Class 2
Risk

K254271 is an FDA 510(k) clearance for the CAPRI. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by ORO Co., Ltd. (Gimpo-Si, KR). The FDA issued a Cleared decision on February 26, 2026 after a review of 58 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all ORO Co., Ltd. devices

Submission Details

510(k) Number K254271 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 2025
Decision Date February 26, 2026
Days to Decision 58 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 115d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 527
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K254271.
CO2 Laser Treatment Machine (CFR3M1)
K253920 · Haidari?Beauty?Technology?(Beijing)?Co.,?, Ltd. · Mar 2026
Medical Alexandrite and Nd:YAG laser Therapy System (CM11LP)
K253828 · Beijing HuaCheng Taike Technology Co., Ltd. · Feb 2026
Medical Ultra-Pico Laser Treatment System (CM-SP-1064&532)
K253829 · Beijing HuaCheng Taike Technology Co., Ltd. · Feb 2026
Diode Laser Therapy Systems (WLA-02)
K252599 · Wingderm Electro-Optics , Ltd. · Feb 2026
BTL-754FF
K252561 · BTL Industries, Inc. · Feb 2026
808nm semiconductor laser hair removal machine
K252048 · Xi'An Taibo Electronic Technology Co., Ltd. · Feb 2026